IP Verse

Icosa competitive analysis

Explore the latest publications and patents granted to Icosa, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Icosa against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3597659	Prevention Of Disulfide Bond Reduction During Recombinant Production Of Polypeptides	GENENTECH	Dec 1, 2023
EP1869065	A Method Of Weak Partitioning Chromatography	WYETH	Feb 5, 2021
EP3103463	Adherent Cells From Adipose Or Placenta Tissues And Use Thereof In Therapy	PLURISTEM	Oct 1, 2020
EP3165227	Composition For Treating Or Preventing Metabolic Disease, Containing, As Active Ingredient, Extracellular Vesicles Derived From Akkermansia Muciniphila Bacteria	MD HEALTHCARE	Dec 13, 2019

Discover the latest PTAB cases involving Icosa, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Icosa with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
FICOSA	-	1	-	-	Non-Active
MEKRA LANG	6	5	-	-	Aggressive